Month: February 2025

SANTA MONICA, Calif., Feb. 27, 2025 (GLOBE NEWSWIRE) — The Macerich Company (NYSE: MAC) has released its Fourth Quarter 2024 Earnings Results and Supplemental Information by posting it to the Investor Relations section of its website at investing.macerich.com. As previously announced, management will hold a conference call at 10:00 a.m. Pacific Time (1:00 p.m. Eastern Time) today, Thursday, February 27, 2025, to discuss quarterly results. Participants who wish to join the conference by telephone must register using the dial-in registration link below to receive the dial-in number and a personalized PIN code that will be required to access the call. Participants may join the live webcast by accessing it at the webcast registration link below or in the Investors Section of the company’s website at investing.macerich.com. Dial-In...

KING OF PRUSSIA, Pa., Feb. 27, 2025 (GLOBE NEWSWIRE) — Vertex, Inc. (NASDAQ: VERX) (“Vertex” or the “Company”), a leading global provider of indirect tax solutions, today announced financial results for its fourth quarter and full year ended December 31, 2024. “Vertex’s 2024 financial results demonstrated the power of our business and financial model, which is built to deliver consistent and durable mid-to-high teens revenue growth with strong earnings leverage and cash flow,” stated David DeStefano, Vertex’s President, Chief Executive Officer and Chairperson of the Board. “We believe the secular tailwinds that enable our performance will accelerate in the coming years as indirect taxes continue to grow in complexity, and enterprise technology continues to evolve and move to the cloud.” Fourth Quarter 2024 Financial ResultsTotal...

~ Announced alignment with the U.S. Food and Drug Administration (FDA) on key elements of the Accelerated Approval pathway for AMT-130 in Huntington’s disease; Initiated preparations for a potential Biologics License Application (BLA) submission ~ ~ Completed patient enrollment in the third cohort of the Phase I/II study of AMT-130 ~ ~ Initiated dosing of the Phase I/II study of AMT-260 in mesial temporal lobe epilepsy (mTLE); Implementing protocol changes to expand study inclusion criteria ~ ~ Completed enrollment of the first cohorts in the Phase I/II studies of AMT-191 in Fabry disease and AMT-162 in SOD1-ALS; Received favorable recommendations from the respective Independent Data Monitoring Committees (IDMC) to proceed with dosing the second cohorts ~ ~ Cash and cash equivalents of approximately $367.5 million as of December 31, 2024,...

Reports another quarter of accelerated growth and profitability, achieved Q4 guidance on Ex TAC gross profit and Adjusted EBITDA, and generated strong cash flow Closed acquisition of Teads in February 2025; Combined company operating under the name Teads NEW YORK, Feb. 27, 2025 (GLOBE NEWSWIRE) — Outbrain Inc. (Nasdaq: OB), which is operating under the new Teads brand, announced today financial results for the quarter and full year ended December 31, 2024. Fourth Quarter and Full Year 2024 Key Financial Metrics:  Three Months EndedDecember 31,   Twelve Months EndedDecember 31,(in millions USD)   2024       2023     % Change     2024       2023     % ChangeRevenue $ 234.6     $ 248.2       (5 )%   $ 889.9     $ 935.8       (5 )%Gross profit   56.1       53.2       5  %     192.1       184.8       4  %Net (loss) income   (0.2 )     4.1       (104 )%     (0.7 )     10.2       (107 )%Net...

Completed Acquisition of Sterling; Issues Full Year 2025 Guidance Full Year 2024 Highlights1Revenues of $860.2 million Net Loss of $(110.3) million, a net loss margin of (12.8)%, includes $130.5 million of expenses incurred related to the acquisition of Sterling Check Corp. (“Sterling”) Adjusted Net Income of $123.7 million Adjusted EBITDA of $249.3 million; Adjusted EBITDA Margin of 29.0% GAAP Diluted Net Loss Per Share of $(0.74), includes $0.66 per share of expenses incurred related to the Sterling acquisition Adjusted Diluted Earnings Per Share of $0.82 Cash Flows from Operations of $28.2 million; Adjusted Operating Cash Flows of $164.5 million, after adjusting for $136.3 million of cash costs directly associated with the Sterling acquisition Closed the Sterling acquisition on October 31, 2024, which was first announced on February...

Strong demand drives 2024 revenue up ~11% to full year record Company beats full year guidance across key metrics and announces 2025 full year guidance MIAMI, Feb. 27, 2025 (GLOBE NEWSWIRE) — Norwegian Cruise Line Holdings Ltd. (NYSE: NCLH) (together with NCL Corporation Ltd. (“NCLC”), “Norwegian Cruise Line Holdings”, “Norwegian”, “NCLH” or the “Company”) today reported financial results for the fourth quarter and full year ended December 31, 2024 and provided guidance for the first quarter and full year 2025. HighlightsGenerated 2024 full year record total revenue of $9.5 billion, increasing ~11% over full year 2023 on 3% capacity growth. GAAP net income was $910.3 million, up 448% compared to 2023, with EPS increasing 386%, to $1.89. 2024 full year Adjusted EBITDA grew 32% to a record $2.45 billion, compared to $1.86 billion...